The remarkable advances in precision medicine are unfortunately not currently available to all patients, especially those being treated in community cancer settings. This growing “gap” is now challenging the health system to provide cost-effective, scalable, innovative solutions for underserved patients. Protean BioDiagnostics was founded to close this gap and accelerate access to precision oncology for all patients, regardless of where they live. To this end, Protean has created an adaptable and innovative framework for rapidly deploying the latest companion diagnostics. Protean’s simplification of universal access to complex diagnostics is poised to change the practice of precision oncology in the community and truly “close the gap.”
In this webinar, you will learn more about
Dr. Anthony Magliocco, MD, FCAP
CEO and Founder, Protean BioDiagnostics
Thank you for your interest in this webinar on "Closing the precision medicine gap in community practice using the power of whole-exome sequencing. If you are interested in a personalized demonstration of the features and capabilities of Qiagen Clinical Insights solutions and would like us to contact you at a specific time, email email@example.com and specify the day, time and phone number to reach you. Please find the link to the recording in your email inbox or start watching the webinar now.
* Mandatory fields